Quarterly report pursuant to Section 13 or 15(d)

Convertible Debt - Related Party (Detail Textuals 1)

v3.19.2
Convertible Debt - Related Party (Detail Textuals 1)
1 Months Ended 6 Months Ended
Jan. 19, 2018
$ / shares
shares
Dec. 28, 2017
USD ($)
Day
$ / shares
Jun. 30, 2018
USD ($)
Short-term Debt [Line Items]      
Proceeds from secured convertible promissory note - related party     $ 400,000
Loss on extinguishment of secured convertible promissory note - related party     $ (590,392)
Emerald Health Sciences Inc      
Short-term Debt [Line Items]      
Initial conversion price | $ / shares $ 0.10    
Number of notes converted into common stock | shares 9,000,000    
Effective interest rate     13.94%
Bridge Loan | Secured promissory note and security agreement | Emerald Health Sciences Inc      
Short-term Debt [Line Items]      
Aggregate gross proceeds   $ 900,000  
Bridge loan interest rate   12.00%  
Initial conversion price | $ / shares   $ 0.10  
Proceeds from secured convertible promissory note - related party   $ 500,000  
Funding of remaining bridge loan   400,000  
Convertible debt   $ 265,000  
Number of trading days as of financing close date | Day   1  
Additional conversion liability   $ 360,000